Anemia and Iron Overload: Prevalence in Patients With MDS

For High-Definition, Click

Azra Raza, MD, discusses that up to 85% of patients with myelodysplastic syndrome (MDS) will also experience anemia. These patients will present with low hemoglobin levels and, depending on their subtype of MDS, up to one-half will require transfusions.

The possibility of iron overload becomes a concern when these patients require multiple transfusions, exceeding a total 20 units of red blood cells, and their serum ferritin is >1000 ng/ml. Raza states that in her practice, at least one-third of the patients with lower-risk MDS who are receiving chronic transfusions will be at risk of iron overload.

Related Videos
Andrew Hantel, MD
Jakub Svoboda, MD
Ponatinib in patients with chronic-phase chronic myeloid leukemia and the T315I mutation: 4-year results from OPTIC
Sujith Samarasinghe, MD
Comparative Efficacy of Bruton Tyrosine Kinase Inhibitors in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia: A Network Meta-Analysis
Michael R. Grunwald, MD, FACP
Shella Saint Fleur-Lominy, MD, PhD
Manali Kamdar, MD
Matthew Matasar, MD, chief, Division of Blood Disorders, Rutgers Cancer Institute; professor, medicine, Rutgers Robert Wood Johnson Medical School
Sattva S. Neelapu, MD